Search - tctmd.com

Displaying 301 - 320 of 460

Sort: Relevancy | Date

Presentation TCT 2016

State-of-the-Art: Recent LVAD Advances and Ongoing Challenges

Presenter: Daniel Burkhoff, Yoshifumi Naka, James W Long

November 01, 2016

Presentation TCT 2016

NuPulse: Implantable Counterpulsation for Advanced CHF

Presenter: David E. Kandzari, Navin K. Kapur, Valluvan Jeevanandam

November 01, 2016

Presentation TCT 2016

First-In-Human Study of the NuPulseCV iVAS for Treating Advanced CHF

Presenter: Emerson C. Perin, Valluvan Jeevanandam

November 01, 2016

Presentation TCT 2016

Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcaval and Subclavian/Axillary Advancements

Presenter: Ulrich P. Jorde, William W. O'Neill, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

Role of Surgical and Transcatheter Tricuspid Valve Repair for Patients With Heart Failure

Presenter: Jeroen J. Bax, Ileana L. Pina, Joachim Schofer

October 31, 2016

Presentation TCT 2016

Surgical and Transcatheter Mitral Valve Repair or Replacement for Patients With Heart Failure and Primary and Secondary MR: Magnitude of Benefit and Prediction of Responders

Presenter: Jeroen J. Bax, Ileana L. Pina, Marco Moscarelli

October 31, 2016

Presentation TCT 2016

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Presenter: Timothy D. Henry, Amit N. Patel, Doris A. Taylor

October 31, 2016

News Conference News TCT 2016

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Michael H. Wilson

October 31, 2016

Presentation TCT 2016

Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and High and Low Gradient Aortic Stenosis: Magnitude of Benefit and Prediction of Responders

Presenter: Jeroen J. Bax, Ileana L. Pina, Ori Ben-Yehuda

October 31, 2016

Presentation TCT 2016

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Presenter: Timothy D. Henry, Amit N. Patel

October 31, 2016

Presentation TCT 2016

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

Presenter: Timothy D. Henry, Amit N. Patel, Steven A.J. Chamuleau

October 31, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

Presentation TCT 2016

Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies: Framingham, TIMI/GRACE, CHADS/HASBLED, DAPT, and Others)

Presenter: Scott Berry, Stuart J. Pocock, Ajay J. Kirtane

October 30, 2016

Presentation TCT 2016

Mediation Analysis: A Method to Assign Attributable Risk

Presenter: Scott Berry, Stuart J. Pocock, Bjorn Redfors

October 30, 2016

Presentation TCT 2016

Surrogate Endpoints: Construction, Validation, and Trustiness

Presenter: Scott Berry, Stuart J. Pocock, William S. Weintraub

October 30, 2016

Presentation TCT 2016

Accounting for the Risk of Competing Events

Presenter: Scott Berry, Stuart J. Pocock, Peter Juni

October 30, 2016

Presentation TCT 2016

Analyzing Repeat Events

Presenter: Scott Berry, Stuart J. Pocock, Eugene H. Blackstone

October 30, 2016

Presentation TCT 2016

Limitations of Composite Endpoints and Strategies for Hierarchical Testing

Presenter: Scott Berry, Stuart J. Pocock, Jan G. P. Tijssen

October 30, 2016

Presentation TCT 2016

Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? Of Course! Renal Patients Are at the Highest Risk!

Presenter: Ian C. Gilchrist, James Nolan, Binita Shah

October 30, 2016

Presentation TCT 2016

Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? No Way, Preserve Future Dialysis Access at All Costs!

Presenter: Ian C. Gilchrist, James Nolan, Michael S. Lee

October 30, 2016

Advertisement

State-of-the-Art: Recent LVAD Advances and Ongoing Challenges

NuPulse: Implantable Counterpulsation for Advanced CHF

First-In-Human Study of the NuPulseCV iVAS for Treating Advanced CHF

Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcaval and Subclavian/Axillary Advancements

Role of Surgical and Transcatheter Tricuspid Valve Repair for Patients With Heart Failure

Surgical and Transcatheter Mitral Valve Repair or Replacement for Patients With Heart Failure and Primary and Secondary MR: Magnitude of Benefit and Prediction of Responders

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and High and Low Gradient Aortic Stenosis: Magnitude of Benefit and Prediction of Responders

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies: Framingham, TIMI/GRACE, CHADS/HASBLED, DAPT, and Others)

Mediation Analysis: A Method to Assign Attributable Risk

Surrogate Endpoints: Construction, Validation, and Trustiness

Accounting for the Risk of Competing Events

Analyzing Repeat Events

Limitations of Composite Endpoints and Strategies for Hierarchical Testing

Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? Of Course! Renal Patients Are at the Highest Risk!

Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? No Way, Preserve Future Dialysis Access at All Costs!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content